Skip to main content

Table 1 Patients' characteristics

From: Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis – a CMR study

Nr

Gender

Age

CAD excluded invasively

ECG

Ck (U/l)

Troponin (ug/l)

BP (mmHg)

BP-FU (mmHg)

Initial medication

Medication at FU

1

Male

20

no

ST-Elevation II, III, aVF, V3-5 T-Inversion I, aVL

443

Troponin I 39.0

125/75

110/60

Metoprolol, Ramipril

Metoprolol, Ramipril

2

Male

36

yes

ST-Elevation V5–V9 T-Inversion III, aVF

407

Troponin I 8.5

138/74

146/92

Metoprolol, Ramipril

None

3

Male

50

yes

ST-Elevation I, II, aVF, V5-6

609

Troponin I 70.0

105/70

n/a

Metoprolol, Ramipril

None

4

Female

50

yes

ST-Elevation V1, V2 T-Inversion I, II, aVL, aVF, V2–V6

 

Troponin I 1.3

120/70

117/49

Ramipril

Ramipril

5

Male

38

yes

ST-Elevation II, III, aVF, V5-6

213

Troponin I 15.7

130/75

110/80

Ramipril

None

6

Female

66

yes

T-Inversion I, II, aVL, V2-6

547

Troponin T 1.8

118/73

122/70

Metoprolol, Ramipril

Metoprolol, Ramipril

7

Male

51

yes

ST-Elevation V2-5 T-Inversion III

349

Troponin T 1.6

n/a

160/96

Metoprolol, Ramipril

Metoprolol

8

Female

24

yes

AV-Block III

125

Troponin T 0.2

120/60

112/51

Metoprolol, Candesartan

None

9

Male

35

yes

ST-Elevation I, II, aVF, V1-3, V5-6

166

Troponin T 0.22

120/75

n/a

Ramipril

Ramipril

10

Male

26

no

ST-Elevation I, II, aVF, V4–V6

85

Troponin I 2.0

125/80

120/80

Metoprolol, Ramipril

Metoprolol, Ramipril

11

Male

37

yes

ST-Elevation I, II, aVL, V4-6

1100

Troponin I 103.0

120/75

115/70

Metoprolol, Ramipril

Metoprolol, Ramipril

12

Female

63

yes

ST-Elevation I, II, aVL, V5-6 T-Inversion III

429

Troponin I 70.1

130/75

100/60

Metoprolol, Ramipril

Ramipril

13

Male

18

yes

ST-Elevation II, III, aVF, V5-6 T-Inversion II, III, aVF, V5-6

168

Troponin I 41.0

120/70

122/56

Metoprolol, Ramipril

None

14

Male

25

yes

ST-Elevation II, III, aVF

1767

Troponin I 198.0

115/70

130/80

Metoprolol, Ramipril

Metoprolol

15

Male

40

yes

ST-Elevation I, II, aVL, V5-6 T-Inversion III

594

Troponin T 1.0

n/a

n/a

Metoprolol, Ramipril

None

16

Male

18

no

initially Afib., later ST-Elevation II, aVF, V3-6

148

Troponin I 0.4

120/70

120/70

Metoprolol, Ramipril

Metoprolol, Ramipril

17

Male

67

yes

ST-Elevation II, III, aVF, V4-6

213

Troponin I 0.4

125/75

130/80

Metoprolol, Ramipril

None

18

Female

43

yes

T-Inversion V1–V3

205

Troponin I 0.4

120/75

130/80

Metoprolol, Ramipril

Metoprolol, Ramipril

19

Male

18

yes

ST-Elevation I, II

52

Troponin I 0.4

120/70

125/95

Metoprolol, Ramipril, Torasemid

Metoprolol, Ramipril

20

Male

16

no

ST-Elevation II, III, aVF

82

Troponin I 0.3

120/70

130/80

Ramipril

Ramipril

21

Male

23

no

ST-Elevation I, II, aVF, V2-5 T-Inversion III

570

Troponin I 0.3

120/60

124/72

None

None

  1. Patients' clinical data at admission (Ck: creatine kinase, CAD: coronary artery disease, BP: blood pressure, FU: follow-up)